Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Moon Biotech

ActiveChinese company · shown for reference, never ranked

Screens a bank of more than 260,000 microbial strains to develop and manufacture microbial products for agriculture, human health and environmental uses.

Food & agriculture›Biological inputsmoonbio.com
HQChina
Last roundSeries C+ · Jul 2024

Chinese company · shown for reference, never ranked

Why →

Uback does not rank or value Chinese companies and no intention can be declared on them. Moon Biotech is shown with dated published facts only, as a reference for the biological inputs segment.

Ranked companies in this segment

#1BioFirstBelgium
#2Pivot BioUnited States
#3Sound AgricultureUnited States
#4VestaronUnited States
#5Invaio SciencesUnited States
#6Aphea.BioBelgium
#7SuperbacBrazil
#8Elicit PlantFrance
#9NewLeaf SymbioticsUnited States
#10MicropepFrance
#11AgroSpheresUnited States
#12AgrivalleBrazil
#13GreenLight BiosciencesUnited States
#14SolubioBrazil
#15MycophytoFrance
#16AgriodorFrance
#17Pluton BiosciencesUnited States
#18BioConsortiaUnited States
#19Solasta BioUnited Kingdom
#20FytekoBelgium
#21GenicaBrazil
#22Ascribe BioUnited States
#23Toopi OrganicsFrance
#24Groundwork BioAgIsrael
#25Harpe Bioherbicide SolutionsUnited States
#26Sea6 EnergyIndia
#27ArevoSweden
#28FA BioUnited Kingdom
#29BioPrime AgriSolutionsIndia
#30Immunrise BiocontrolFrance
#31Evologic TechnologiesAustria
#32WAKUJapan

Full biological inputs ranking →

Funding history

DateRoundAmountTypeInvestors
Jul 2024Series C+USD 41.3MEquitySDIC Juli

About CNY 300M.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Biological inputs · worldwideFor reference, never ranked—Edition 0 · Oct 202612 Feb 2027

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Moon Biotech as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is Moon Biotech worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.